Correction to: Oncogene https://doi.org/10.1038/s41388-020-01626-z
The authors have noticed that an error in Fig. 6A. In the week 2 panel, one of the mice from the N4 10 mg/kg group was inadvertently duplicated with a mouse from the C188-9 group in week 2. Figures 6A have now been corrected as shown below. The authors confirm the corrections do not affect the results or conclusions of this work, and wish to apologies for any inconvenience caused by these inadvertent errors.
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Chen, H., Bian, A., Yang, Lf. et al. Correction: Targeting STAT3 by a small molecule suppresses pancreatic cancer progression. Oncogene 43, 2132–2134 (2024). https://doi.org/10.1038/s41388-024-03044-x
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41388-024-03044-x
- Springer Nature Limited